HK1100845A1 - Phenyl diazepane carboxamides and annelated phenylpiperazine carboxamides containing oxygen and use d as dopamine d3 antagonists - Google Patents

Phenyl diazepane carboxamides and annelated phenylpiperazine carboxamides containing oxygen and use d as dopamine d3 antagonists

Info

Publication number
HK1100845A1
HK1100845A1 HK07105930A HK07105930A HK1100845A1 HK 1100845 A1 HK1100845 A1 HK 1100845A1 HK 07105930 A HK07105930 A HK 07105930A HK 07105930 A HK07105930 A HK 07105930A HK 1100845 A1 HK1100845 A1 HK 1100845A1
Authority
HK
Hong Kong
Prior art keywords
carboxamides
annelated
diazepane
phenylpiperazine
dopamine
Prior art date
Application number
HK07105930A
Other languages
English (en)
Inventor
Gmeiner Peter
Huebner Harald
Schlotter Karin
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of HK1100845A1 publication Critical patent/HK1100845A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Addiction (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • External Artificial Organs (AREA)
HK07105930A 2004-12-30 2007-06-05 Phenyl diazepane carboxamides and annelated phenylpiperazine carboxamides containing oxygen and use d as dopamine d3 antagonists HK1100845A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004063797A DE102004063797A1 (de) 2004-12-30 2004-12-30 Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide
PCT/EP2005/014047 WO2006072430A1 (fr) 2004-12-30 2005-12-27 Carboxamides de phenyle piperazine et de phenyle diazepane anneles et contenant de l'oxygene en tant qu'antagonistes de la dopamine d3

Publications (1)

Publication Number Publication Date
HK1100845A1 true HK1100845A1 (en) 2007-09-28

Family

ID=36102609

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07105930A HK1100845A1 (en) 2004-12-30 2007-06-05 Phenyl diazepane carboxamides and annelated phenylpiperazine carboxamides containing oxygen and use d as dopamine d3 antagonists

Country Status (22)

Country Link
US (1) US20080194539A1 (fr)
EP (1) EP1761524B1 (fr)
JP (1) JP2008526700A (fr)
KR (1) KR20070102673A (fr)
CN (1) CN101027294A (fr)
AU (1) AU2005324107A1 (fr)
BR (1) BRPI0519485A2 (fr)
CA (1) CA2576332A1 (fr)
DE (2) DE102004063797A1 (fr)
DK (1) DK1761524T3 (fr)
EA (1) EA200701366A1 (fr)
ES (1) ES2297767T3 (fr)
HK (1) HK1100845A1 (fr)
HR (1) HRP20080075T3 (fr)
IL (1) IL180763A0 (fr)
MX (1) MX2007006369A (fr)
NO (1) NO20072587L (fr)
PL (1) PL1761524T3 (fr)
PT (1) PT1761524E (fr)
SI (1) SI1761524T1 (fr)
WO (1) WO2006072430A1 (fr)
ZA (1) ZA200701972B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5701213B2 (ja) * 2008-10-10 2015-04-15 インスティチュート オブ ファーマコロジー アンド トキシコロジー アカデミー オブ ミリタリー メディカル サイエンシズ ピー．エル．エー．チャイナ 新規なドーパミンｄ３受容体リガンド、その調製及び使用
US9227944B2 (en) 2008-10-10 2016-01-05 Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China Dopamine D3 receptor ligands and preparation and medical uses of the same
CA2754904A1 (fr) * 2009-03-10 2010-09-16 Takeda Pharmaceutical Company Limited Derives de la coumarone
CN103282369A (zh) * 2011-04-08 2013-09-04 劳乐斯实验室私营有限公司 抗逆转录病毒化合物与抗氧化酸的固体形式、其制备方法以及其药物组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90279A (en) * 1988-05-24 1995-03-30 American Home Prod History of piperazinyl carboxamide, their preparation and the pharmaceutical preparations containing them
NZ231631A (en) * 1988-12-08 1992-07-28 Duphar Int Res Heterocyclically-substituted piperazine and diazepine derivatives and anxiolytic compositions
DE4127849A1 (de) * 1991-08-22 1993-02-25 Merck Patent Gmbh Benzodioxanderivate
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
CA2297825C (fr) * 1997-07-25 2006-03-14 H. Lundbeck A/S Derives indole et 2,3-dihydro-indole, leur preparation et utilisation
FR2781671A1 (fr) * 1998-07-28 2000-02-04 Synthelabo Compositions pharmaceutiques contenant un inhibiteur de la recapture de la serotonine et leur application en therapeutique
AR022303A1 (es) * 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
GB9905010D0 (en) * 1999-03-04 1999-04-28 Merck Sharp & Dohme Therapeutic agents
ES2188344B1 (es) * 2000-11-29 2004-09-16 Laboratorios Vita, S.A. Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.
HUP0103987A3 (en) * 2001-09-28 2004-11-29 Richter Gedeon Vegyeszet Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates
MXPA05000033A (es) * 2002-07-04 2005-04-08 Sanol Arznei Schwarz Gmbh Utilizacion de carboxamida de heteroareno como ligandos de dopamina-d3 para el tratamiento de enfermedades de cns.
US7605259B2 (en) * 2002-09-14 2009-10-20 University Of North Texas Health Science Center At Fort Worth Structurally rigid dopamine d3 receptor selective ligands and process for making them
DE10259244A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh N-(Indolethyl-)cycloamin-Verbindungen
WO2004082686A2 (fr) * 2003-03-13 2004-09-30 Dynogen Pharmaceuticals, Inc. Methodes d'utilisation de composes presentant des activites combinees 5-ht1a et ssri, en fonction des besoins, pour traiter dysfonction sexuelle

Also Published As

Publication number Publication date
PT1761524E (pt) 2008-02-21
US20080194539A1 (en) 2008-08-14
AU2005324107A1 (en) 2006-07-13
CA2576332A1 (fr) 2006-07-13
NO20072587L (no) 2007-05-21
EA200701366A1 (ru) 2008-02-28
MX2007006369A (es) 2007-07-11
WO2006072430A1 (fr) 2006-07-13
ZA200701972B (en) 2008-04-30
CN101027294A (zh) 2007-08-29
HRP20080075T3 (en) 2008-03-31
EP1761524A1 (fr) 2007-03-14
JP2008526700A (ja) 2008-07-24
ES2297767T3 (es) 2008-05-01
EP1761524B1 (fr) 2007-11-21
AU2005324107A2 (en) 2006-07-13
DE502005002058D1 (de) 2008-01-03
SI1761524T1 (sl) 2008-04-30
KR20070102673A (ko) 2007-10-19
BRPI0519485A2 (pt) 2009-02-03
PL1761524T3 (pl) 2008-04-30
DE102004063797A1 (de) 2006-07-13
DK1761524T3 (da) 2008-04-07
IL180763A0 (en) 2007-06-03

Similar Documents

Publication Publication Date Title
EP1790639A4 (fr) Composé contenant un groupe basique et utilisation
HK1110592A1 (en) Novel carboxamides for use as xa inhibitors
EP2104492A4 (fr) Alimentation en oxygène pour greffe de cellules et vascularisation
IL181524A0 (en) Heterocyclic compounds and methods of use
EP2039184A4 (fr) Composition de l'interface utilisateur locale avec interface utilisateur générée à distance et support multimédia
EP2054798A4 (fr) Distribution et gestion de listes de diffusion utilisant le contenu
EP1718621A4 (fr) Composes precurseurs de nitroxyle et methodes d'utilisation
HK1103074A1 (en) Heteroaryl-ureas and their use as glucokinase activators
IL176958A0 (en) Compounds and methods of use
EP1757658A4 (fr) Composition de caoutchouc et utilisation de cette dernière
EP2032156A4 (fr) Compositions et procédés pour administrer de l'oxygène
EP2023718A4 (fr) Composés de ligand de créatine et procédés d'utilisation correspondants
IL179747A0 (en) Novel indazole carboxamides and their use
IL194028A0 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
EP1812451A4 (fr) Composes et methodes d'utilisation de ces composes
EP2099597A4 (fr) Moule de bloc de récepteur et utilisation de celui-ci
GB2401318B (en) Incubator with oxygen metering
GB0607798D0 (en) Novel polypeptides and use thereof
HK1100845A1 (en) Phenyl diazepane carboxamides and annelated phenylpiperazine carboxamides containing oxygen and use d as dopamine d3 antagonists
EP2039422A4 (fr) Matière de stockage d'oxygène
EP2039695A4 (fr) Composé hétérocyclique bicycique et son utilisation
EP2069371A4 (fr) Composés d'organo-arsénoxydes et leur utilisation
EP2101575A4 (fr) Composés activateurs de l'ace2 et procédés d'utilisation de ceux-ci
IL192820A0 (en) Novel compounds and use thereof
EP1841748A4 (fr) Composés de type organosélénium et applications

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111227